Ocuphire Pharma Inc. buy El_Zocko
Start price
27.02.15
/
50%
€3,790.1
Target price
07.04.15
€4,896.0
Performance (%)
-3.80%
End price
07.04.15
€3,646.1
Summary
This prediction ended on 07.04.15 with a price of €3,646.1. With a performance of -3.80%, the BUY prediction by El_Zocko finished with a loss. El_Zocko has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ocuphire Pharma Inc. | -1.947% | -1.947% | -69.265% | -69.891% |
iShares Core DAX® | -1.414% | 7.218% | 17.151% | 15.732% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% | 30.945% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% | 2.733% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% | 34.852% |
Comments by El_Zocko for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
REXAHN PHARMACEUTICALS
Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing the next generation of targeted therapeutics for the treatment of cancer.
Rexahn's clinical development programs target specific proteins that are selectively localized in human cancer cells and not in healthy tissues resulting in increased efficacy and reduced toxicity.
http://www.rexahn.com/cms/
(Vom Mitglied beendet)